Umbilical cord blood is an alternative hematopoietic stem cell source for patients with
hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation …

In recent years there seems to be an unbounded interest concerning mesenchymal stem
cells (MSCs). This is mainly attributed to their exciting characteristics including long-term ex …

Background Hematopoietic stem-cell transplantation (HSCT) is a potentially lifesaving
therapy for several blood cancers and other diseases. For patients without a suitable related …

Background Promising results of cord-blood transplants from unrelated donors have been
reported in adults. Methods We compared outcomes in 682 adults with acute leukemia who …

Purpose Establishment of hematopoietic stem-cell (HSC) transplantation from mismatched
relatives is feasible for patients with acute leukemia. As our original method of graft …

We studied the effect of allele-level matching at human leukocyte antigen (HLA)-A,-B,-C, and-
DRB1 in 1568 single umbilical cord blood (UCB) transplantations for hematologic …

The majority of cord blood transplantations (CBTs) have human leukocyte antigen (HLA)
disparities. We investigated the impact that patients' pretransplantation anti-HLA antibodies …

Since the first human cord blood transplant, performed in 1988, cord blood banks have been
established worldwide for collection and cryopreservation of cord blood for allogeneic …

Outcomes of unrelated donor cord blood transplantation in 191 hematologic malignancy
children (median age, 7.7 years; median weight, 25.9 kg) enrolled between 1999 and 2003 …

Umbilical cord blood (UCB) transplantation is potentially curative for acute leukemia. This
analysis was performed to identify risk factors associated with leukemia relapse following …